The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
World Health Organization Ranking of Antimicrobials According to Their Importance in Human Medicine: A Critical Step for Developing Risk Management Strategies to Control Antimicrobial Resistance From Food Animal Production
Abstract
Antimicrobial use in food animals selects for antimicrobial resistance in bacteria, which can spread to people. Reducing use of antimicrobials-particularly those deemed to be critically important for human medicine-in food production animals continues to be an important step for preserving the benefits of these antimicrobials for people. The World Health Organization ranking of antimicrobials according to their relative importance in human medicine was recently updated. Antimicrobials considered the highest priority among the critically important antimicrobials were quinolones, third- and fourth-generation cephalosporins, macrolides and ketolides, and glycopeptides. The updated ranking allows stakeholders in the agriculture sector and regulatory agencies to focus risk management efforts on drugs used in food animals that are the most important to human medicine. In particular, the current large-scale use of fluoroquinolones, macrolides, and third-generation cephalosporins and any potential use of glycopeptides and carbapenems need to be addressed urgently.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Global trends in antimicrobial use in food animals
Van Boeckel, T. P., Brower, C., Gilbert, M., Grenfell, B. T., Levin, S. A., Robinson, T. P., Teillant, A., & Laxminarayan, R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503141112 · Cited by 3,973
Outpatient antibiotic use in Europe and association with resistance: a cross-national database study
Goossens, H., Ferech, M., Vander Stichele, R., & Elseviers, M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17907-0 · Cited by 3,359
Understanding the mechanisms and drivers of antimicrobial resistance
Holmes, A. H., Moore, L. S. P., Sundsfjord, A., Steinbakk, M., Regmi, S., Karkey, A., Guerin, P. J., & Piddock, L. J. V. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00473-0 · Cited by 2,611
Walsh, T. R., Weeks, J., Livermore, D. M., & Toleman, M. A. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70059-7 · Cited by 1,250
Hu, X., Zhou, Q., & Luo, Y. (2010) · Environmental Pollution · doi:10.1016/j.envpol.2010.05.023 · Cited by 926
Staphylococcus aureus CC398: Host Adaptation and Emergence of Methicillin Resistance in Livestock
Price, L. B., Stegger, M., Hasman, H., Aziz, M., Larsen, J., Andersen, P. S., Pearson, T., Waters, A. E., Foster, J. T., Schupp, J., et al. (2012) · mBio · doi:10.1128/mbio.00305-11 · Cited by 858
Cited by
Antimicrobial Resistance: a One Health Perspective
McEwen, S. A., & Collignon, P. J. (2018) · Microbiology Spectrum · doi:10.1128/microbiolspec.arba-0009-2017 · Cited by 1,199
Self-citationAntibiotics and Food Safety in Aquaculture
Chen, J., Sun, R., Pan, C., Sun, Y., Mai, B., & Li, Q. X. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c03996 · Cited by 516
Antibiotic use in food animals worldwide, with a focus on Africa: Pluses and minuses
Van, T. T. H., Yidana, Z., Smooker, P. M., & Coloe, P. J. (2020) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2019.07.031 · Cited by 451
Miranda, C. D., Godoy, F. A., & Lee, M. R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01284 · Cited by 339
Mechanisms of quinolone action and resistance: where do we stand?
Correia, S., Poeta, P., Hébraud, M., Capelo, J. L., & Igrejas, G. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000475 · Cited by 332
Authority, E. F. S., & European Centre for Disease Prevention and Control (2019) · EFSA Journal · doi:10.2903/j.efsa.2019.5598 · Cited by 300
History and Current Use of Antimicrobial Drugs in Veterinary Medicine
Prescott, J. F. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.arba-0002-2017 · Cited by 296
Ajulo, S., & Awosile, B. (2024) · PLOS ONE · doi:10.1371/journal.pone.0297921 · Cited by 267
Structural basis of Pseudomonas biofilm-forming functional amyloid FapC formation
Hansen, K. H., Golcuk, M., Byeon, C. H., Tunc, A., Plechinger, E. B., Dueholm, M. K. D., Conway, J. F., Andreasen, M., Gur, M., & Akbey, Ü. (2025) · Science Advances · doi:10.1126/sciadv.adx7829 · Cited by 18
Sah, A. K., & Feglo, P. K. (2022) · Pan African Medical Journal · doi:10.11604/pamj.2022.43.207.33734 · Cited by 4
“Quinolones are also one of the major options for the treatment of infections caused by dangerous and multidrug-resistant bacteria [1].”
BackgroundInfluential
Metadata
- Authors
- Collignon, P. C., Conly, J. M., Andremont, A., McEwen, S. A., & Aidara-Kane, A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-07-20
- Volume
- 63
- Issue
- 8
- Pages
- 1087-1093
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2482741214
- Cited by
- 328
- References
- 28
- FWCI
- 18.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.